These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary. Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561 [TBL] [Abstract][Full Text] [Related]
3. Drugs for cognitive loss and dementia. Treat Guidel Med Lett; 2007 Feb; 5(54):9-14. PubMed ID: 17261969 [No Abstract] [Full Text] [Related]
4. Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement. Brousseau G; Rourke BP; Burke B Exp Clin Psychopharmacol; 2007 Dec; 15(6):546-54. PubMed ID: 18179307 [TBL] [Abstract][Full Text] [Related]
5. Antipsychotics and cognitive function. Azumi M; Ishizuka S; Fujii M; Sasaki H Psychogeriatrics; 2011 Jun; 11(2):79-82. PubMed ID: 21707854 [No Abstract] [Full Text] [Related]
6. Navigating patients and caregivers through the course of Alzheimer's disease. Aupperle PM J Clin Psychiatry; 2006; 67 Suppl 3():8-14; quiz 23. PubMed ID: 16649846 [TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease care management plan: maximizing patient care. Treinkman A J Am Acad Nurse Pract; 2005 Mar; Suppl():8-9. PubMed ID: 16033024 [TBL] [Abstract][Full Text] [Related]
8. The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches. Hake AM Semin Neurol; 2002 Mar; 22(1):71-4. PubMed ID: 12170395 [TBL] [Abstract][Full Text] [Related]
9. Changes in utilisation of anticholinergic drugs after initiation of cholinesterase inhibitors. Robinson M; Rowett D; Leverton A; Mabbott V Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):659-64. PubMed ID: 19548222 [TBL] [Abstract][Full Text] [Related]
10. [Modern therapy for dementia]. Padberg F; Möller HJ; Bottlender R; Hampel H MMW Fortschr Med; 2005 May; 147 Spec No 2():71-4, 76-7. PubMed ID: 15968877 [TBL] [Abstract][Full Text] [Related]
11. Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study. Caballero J; Hitchcock M; Scharre D; Beversdorf D; Nahata MC Clin Ther; 2006 Oct; 28(10):1695-700. PubMed ID: 17157125 [TBL] [Abstract][Full Text] [Related]
12. [Biological therapies of behavioral and psychological symptoms of dementia: update and prospects]. Gallarda T; Olie JP Encephale; 2000; 26(3):72-80. PubMed ID: 10951909 [TBL] [Abstract][Full Text] [Related]
13. New therapeutic approaches to Alzheimer's disease. Schneider LS J Clin Psychiatry; 1996; 57 Suppl 14():30-6. PubMed ID: 9024334 [TBL] [Abstract][Full Text] [Related]
14. [Rivastigmine: a review of its clinical effectiveness]. Spiegel R Rev Neurol; 2002 Nov 1-15; 35(9):859-69. PubMed ID: 12436385 [TBL] [Abstract][Full Text] [Related]
15. Current issues in dementia pharmacotherapy. Daiello LA Am J Manag Care; 2007 Dec; 13 Suppl 8():S198-202. PubMed ID: 18095783 [TBL] [Abstract][Full Text] [Related]
16. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies. Tariot PN J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847 [TBL] [Abstract][Full Text] [Related]
17. New therapeutic approaches to cognitive impairment. Schneider LS J Clin Psychiatry; 1998; 59 Suppl 11():8-13. PubMed ID: 9731544 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas. Omerovic M; Hampel H; Teipel SJ; Buerger K World J Biol Psychiatry; 2008; 9(1):69-75. PubMed ID: 17886162 [TBL] [Abstract][Full Text] [Related]
19. Choosing treatment for Alzheimer's patients and their caregivers. Schneider LS; Porsteinsson AP; Peskin ER; Pfeiffer EA Geriatrics; 2003 Aug; 58 Suppl 1():3-18, 23; quiz 19-22. PubMed ID: 12961833 [No Abstract] [Full Text] [Related]